NO164237C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring. - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring.Info
- Publication number
- NO164237C NO164237C NO845250A NO845250A NO164237C NO 164237 C NO164237 C NO 164237C NO 845250 A NO845250 A NO 845250A NO 845250 A NO845250 A NO 845250A NO 164237 C NO164237 C NO 164237C
- Authority
- NO
- Norway
- Prior art keywords
- pyridin
- tioeters
- cycloalifatic
- nitrogenic
- eters
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical class [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3347276 | 1983-12-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO845250L NO845250L (no) | 1985-07-01 |
| NO164237B NO164237B (no) | 1990-06-05 |
| NO164237C true NO164237C (no) | 1990-09-12 |
Family
ID=6218282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO845250A NO164237C (no) | 1983-12-28 | 1984-12-27 | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4643995A (no) |
| EP (1) | EP0149088B1 (no) |
| JP (1) | JPS60169476A (no) |
| KR (1) | KR870000354B1 (no) |
| CN (1) | CN85101353A (no) |
| AT (1) | ATE40131T1 (no) |
| AU (1) | AU566560B2 (no) |
| DD (1) | DD231354A5 (no) |
| DE (2) | DE3443968A1 (no) |
| DK (1) | DK613384A (no) |
| ES (1) | ES8607014A1 (no) |
| FI (1) | FI84062C (no) |
| GB (1) | GB2152048B (no) |
| GR (1) | GR82596B (no) |
| HU (1) | HU194209B (no) |
| IL (1) | IL73608A (no) |
| NO (1) | NO164237C (no) |
| PT (1) | PT79736B (no) |
| SU (1) | SU1417796A3 (no) |
| ZA (1) | ZA848275B (no) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA836994B (en) * | 1982-09-30 | 1984-05-30 | Robins Co Inc A H | Fused aromatic oxazepinones and sulfur analogs thereof |
| DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
| US4853027A (en) * | 1986-09-08 | 1989-08-01 | E. I. Du Pont De Nemours And Company | Phytotoxic 2-alkyl-5-(heterocyclic)-pyrrole-3,4-dicarboxylates |
| EP0287908A3 (de) * | 1987-04-18 | 1989-12-27 | ASTA Medica Aktiengesellschaft | Neue stickstoffhaltige, cycloaliphatische Verbindungen mit einem Aminosäurerest sowie einem Pyridinrest |
| GB8718445D0 (en) * | 1987-08-04 | 1987-09-09 | Wyeth John & Brother Ltd | Pyridyl-ethers |
| CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
| FR2655649B1 (fr) * | 1989-12-12 | 1994-07-08 | Adir | Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| MX9100517A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
| IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
| US5948793A (en) * | 1992-10-09 | 1999-09-07 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release |
| US5914328A (en) * | 1992-10-09 | 1999-06-22 | Abbott Laboratories | Heterocyclic ether compounds useful in controlling neurotransmitter release |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610741B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| US6437138B1 (en) | 1996-06-06 | 2002-08-20 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| US6133253A (en) * | 1996-12-10 | 2000-10-17 | Abbott Laboratories | 3-Pyridyl enantiomers and their use as analgesics |
| CA2306477A1 (en) * | 1997-11-05 | 1999-05-20 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| PE20000728A1 (es) * | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
| JP2003529547A (ja) * | 1999-09-14 | 2003-10-07 | アボット・ラボラトリーズ | 化学シナプス伝達のコントロールに有効な３−ピロリジニルオキシ−３’−ピリジルエーテル化合物 |
| DE10000739A1 (de) * | 2000-01-11 | 2001-07-12 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| US6436916B1 (en) | 2000-10-12 | 2002-08-20 | Alvin Guttag | Ibuprofen-aspirin and hydroxymethylacylfulvene analogs |
| EP1467986A1 (en) | 2002-01-17 | 2004-10-20 | Eli Lilly And Company | Aza-cyclic compounds as modulators of acetylcholine receptors |
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| BRPI0406761A (pt) | 2003-01-14 | 2005-12-20 | Arena Pharm Inc | Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia |
| CN100368409C (zh) * | 2003-06-24 | 2008-02-13 | 神经研究公司 | 8-氮杂双环[3.2.1]辛烷衍生物及其用于制备单胺神经递质再摄取抑制剂的用途 |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| CN1997640A (zh) * | 2004-06-04 | 2007-07-11 | 艾尼纳制药公司 | 作为代谢调节剂的经取代芳基和杂芳基衍生物及其相关病症的预防和治疗 |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| US7413805B2 (en) * | 2005-02-25 | 2008-08-19 | Fry's Metals, Inc. | Preparation of metallic particles for electrokinetic or electrostatic deposition |
| NZ565898A (en) * | 2005-09-16 | 2010-07-30 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| MY147661A (en) | 2006-05-19 | 2012-12-31 | Abbott Lab | Fused bicycloheterocycle substituted azabicyclic alkane derivatives |
| TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| MY148544A (en) | 2007-05-23 | 2013-04-30 | Merck Sharp & Dohme | Pyridyl piperidine orexin receptor antagonists |
| WO2010048014A1 (en) * | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,4-disubstituted pyrrolidine orexin receptor antagonists |
| CA2739917A1 (en) | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted morpholine orexin receptor antagonists |
| JP2012506374A (ja) | 2008-10-21 | 2012-03-15 | メルク・シャープ・エンド・ドーム・コーポレイション | ２，５−二置換ピペリジンオレキシン受容体アンタゴニスト |
| EP4148045A1 (en) | 2010-01-27 | 2023-03-15 | Arena Pharmaceuticals, Inc. | Intermediate compounds for the preparation of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl)acetic acid and salts thereof |
| AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
| AU2016205361C1 (en) | 2015-01-06 | 2021-04-08 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| IL285890B (en) | 2015-06-22 | 2022-07-01 | Arena Pharm Inc | Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid |
| US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE630125A (no) * | ||||
| GB1041342A (en) * | 1962-03-27 | 1966-09-07 | Degussa | New pyridine derivatives |
| GB1054338A (no) * | 1963-07-11 | |||
| US3308129A (en) * | 1964-06-05 | 1967-03-07 | Smith Kline French Lab | 3-tropanyl esters of atropic and thioatropic acids |
| GB1306139A (no) * | 1970-08-06 | 1973-02-07 | ||
| US3905984A (en) * | 1971-03-09 | 1975-09-16 | Smith Kline French Lab | Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas |
| FR2187317B2 (no) * | 1972-06-07 | 1975-06-20 | Hexachimie | |
| US3956294A (en) * | 1972-06-22 | 1976-05-11 | Cassella Farbwerke Mainkur Aktiengesellschaft | Substituted pyridine compounds |
| US3947463A (en) * | 1972-06-22 | 1976-03-30 | Cassella Farbwerke Mainkur Ag | Certain 2-amino-nicotinonitrile derivatives |
| US3980659A (en) * | 1972-06-22 | 1976-09-14 | Cassella Farbwerke Mainkur Aktiengesellschaft | Certain 6-amino-4-hydrocarbyl-nicotinamides |
| US4061642A (en) * | 1972-06-22 | 1977-12-06 | Cassella Farbwerke Mainkur Ag | 2,4,6-Trisubstituted-3-pyridine carboxamides |
| US3946024A (en) * | 1972-06-22 | 1976-03-23 | Cassella Farbwerke Mainkur Ag | 2-Hydrocarbyloxy-pyridine compounds |
| US3954782A (en) * | 1972-06-22 | 1976-05-04 | Cassella Farbwerke Mainkur Aktiengesellschaft | 2,6-Hydrazino-3-pyridine carboxyamides |
| DE2549999A1 (de) * | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Piperidin-derivate und verfahren zu ihrer herstellung |
| DE2905876A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US4203990A (en) * | 1979-04-30 | 1980-05-20 | G. D. Searle & Co. | Anti-diarrheal 2-substituted quinuclidines |
| FR2459240A1 (fr) * | 1979-06-21 | 1981-01-09 | Cm Ind | Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent |
| DE3045688A1 (de) * | 1980-12-04 | 1982-07-08 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue 8-arylalkyl-3-phenyl-3-nortropanole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung |
| IT1190942B (it) * | 1982-08-04 | 1988-02-24 | Poli Ind Chimica Spa | Composto ad attivita' analgesica ed antiinfiammatoria,suo procedimento di preparazione e relative composizioni farmaceutiche |
-
1984
- 1984-10-23 ZA ZA848275A patent/ZA848275B/xx unknown
- 1984-11-23 IL IL73608A patent/IL73608A/xx unknown
- 1984-12-01 DE DE19843443968 patent/DE3443968A1/de not_active Withdrawn
- 1984-12-01 AT AT84114607T patent/ATE40131T1/de not_active IP Right Cessation
- 1984-12-01 DE DE8484114607T patent/DE3476205D1/de not_active Expired
- 1984-12-01 EP EP84114607A patent/EP0149088B1/de not_active Expired
- 1984-12-17 US US06/682,773 patent/US4643995A/en not_active Expired - Fee Related
- 1984-12-20 AU AU36996/84A patent/AU566560B2/en not_active Ceased
- 1984-12-20 DK DK613384A patent/DK613384A/da not_active Application Discontinuation
- 1984-12-20 GB GB08432162A patent/GB2152048B/en not_active Expired
- 1984-12-21 SU SU843826165A patent/SU1417796A3/ru active
- 1984-12-21 PT PT79736A patent/PT79736B/pt not_active IP Right Cessation
- 1984-12-25 JP JP59272172A patent/JPS60169476A/ja active Pending
- 1984-12-27 FI FI845126A patent/FI84062C/fi not_active IP Right Cessation
- 1984-12-27 GR GR82596A patent/GR82596B/el unknown
- 1984-12-27 DD DD84271863A patent/DD231354A5/de unknown
- 1984-12-27 NO NO845250A patent/NO164237C/no unknown
- 1984-12-27 ES ES539076A patent/ES8607014A1/es not_active Expired
- 1984-12-28 KR KR1019840008498A patent/KR870000354B1/ko not_active IP Right Cessation
- 1984-12-28 HU HU844869A patent/HU194209B/hu not_active IP Right Cessation
-
1985
- 1985-04-01 CN CN198585101353A patent/CN85101353A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL73608A0 (en) | 1985-02-28 |
| SU1417796A3 (ru) | 1988-08-15 |
| GB8432162D0 (en) | 1985-01-30 |
| GR82596B (en) | 1985-04-29 |
| NO845250L (no) | 1985-07-01 |
| NO164237B (no) | 1990-06-05 |
| DD231354A5 (de) | 1985-12-24 |
| AU566560B2 (en) | 1987-10-22 |
| FI845126L (fi) | 1985-06-29 |
| DK613384A (da) | 1985-06-29 |
| DK613384D0 (da) | 1984-12-20 |
| US4643995A (en) | 1987-02-17 |
| PT79736A (de) | 1985-01-01 |
| ES539076A0 (es) | 1986-05-16 |
| ES8607014A1 (es) | 1986-05-16 |
| CN85101353A (zh) | 1986-10-15 |
| JPS60169476A (ja) | 1985-09-02 |
| FI84062C (fi) | 1991-10-10 |
| HUT36115A (en) | 1985-08-28 |
| GB2152048A (en) | 1985-07-31 |
| HU194209B (en) | 1988-01-28 |
| KR850004755A (ko) | 1985-07-27 |
| EP0149088A1 (de) | 1985-07-24 |
| ZA848275B (en) | 1985-08-28 |
| AU3699684A (en) | 1985-07-04 |
| FI845126A0 (fi) | 1984-12-27 |
| PT79736B (de) | 1986-12-30 |
| ATE40131T1 (de) | 1989-02-15 |
| KR870000354B1 (ko) | 1987-03-05 |
| EP0149088B1 (de) | 1989-01-18 |
| FI84062B (fi) | 1991-06-28 |
| GB2152048B (en) | 1987-11-11 |
| DE3443968A1 (de) | 1985-10-31 |
| IL73608A (en) | 1987-12-31 |
| DE3476205D1 (en) | 1989-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164237C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring. | |
| KR900700465A (ko) | 화합물 | |
| NO163569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-thioxanthinderivater. | |
| ES8601915A1 (es) | Un procedimiento para preparar derivados de piridazinona | |
| NO164982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| DK521685A (da) | Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning | |
| NO165393C (no) | Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre. | |
| NO865148L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider. | |
| NO153295C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(aryloxyalkyl)-n`-(aminoalkyl)-ureaderivater. | |
| NO158803C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n[-propargylpiperazin. | |
| NO167982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater. | |
| NO165999C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-(2-aminoetyl)benzamid-derivater. | |
| SE8303539D0 (sv) | Polyenverbindungen | |
| NO873571L (no) | Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat. | |
| ES8304932A1 (es) | Un procedimiento para la preparacion de derivados de cistina". | |
| ES450206A1 (es) | Un procedimiento para la preparacion de 1, 2, 3, 4-tetrahi- droisoquinoleinas. | |
| ES8104265A1 (es) | Un procedimiento para la preparacion de nuevas bencenosulfi-namidas | |
| NO168642C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid. | |
| GB2011887A (en) | Antiallergic agent | |
| NO158577C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminforbindelser. |